	Timing of cranial radiotherapy in HER2-positive breast Cancer brain metastases treated with Pyrotinib: a multicentre real-world cohort study. Clin Transl Radiat Oncol Chen Z, Jing H, Huang S, Wang M, Mao D, Li L, Lu S, Zhou X, Bi D, Zhang Y, Chen X, Ma Y, Xia Y, Yi J, Hou Y. PMID: 42927325 [PubMed]
	A HALF CENTURY OF PROGRESS IN BREAST CANCER: WHERE DO WE GO NEXT? Trans Am Clin Climatol Assoc Winer EP. PMID: 42927318 [PubMed - indexed for MEDLINE]
	Baseline prevalence of lung cancer screening and associated factors among women in breast cancer screening clinics prior to the Pink & Pearl program: A retrospective analysis of electronic health records. Res Sq Odeny B, Ramaswamy SG, Bowe B, Zewde E, Mnatzakanian A, Akinloye B, Odeny T, Lee MV. PMID: 42926932 [PubMed]
	Thrombotic Risk of Targeted Therapies in Breast Cancer: A Real-World Cohort Study. Res Sq Boland W, Guzik G, Grinsztejn E, Perez JA, Plevniak K, Bannow BS, Nayak L, Martin J. PMID: 42926660 [PubMed]
	Menopause timing, hormone therapy, epigenetic aging, and breast cancer outcomes: a secondary analysis of the PLCO Cancer Screening Trial. medRxiv Zhai T, Pankratz VS, Zychowski KE, Li Y, Leslie KK, Guo Y, Amos CI, Cook LS, Leng S. PMID: 42926595 [PubMed]
	Pembrolizumab Plus Chemotherapy for HR+/HER2- PD-L1â€’Positive Advanced Breast Cancer: Final Analysis of the Phase 3 KEYNOTE-B49 Study. Ann Oncol Rugo HS, Kok M, Goncalves A, Loirat D, Bianchini G, Fasching PA, Cescon DW, Díaz RR, Zagouri F, Korbenfeld E, Dalenc F, Gilarranz YJ, Hashimoto J, Park YH, Im SA, Hu X, Hirshfield KM, Jia L, Tryfonidis K, Schmid P. PMID: 42926111 [PubMed - as supplied by publisher]
	Atirmociclib and fulvestrant for patients with HR+/HER2- advanced/metastatic breast cancer who progressed on a prior cyclin-dependent kinase 4/6 inhibitor: primary analysis of the randomized FourLight-1 trial. Ann Oncol Giordano A, Xu B, Yoshinami T, Huang CS, Park YH, Lerzo GL, Li H, Shai A, Jaliffe GG, Itoh M, Williams A, Goel S, Im SA, Cobb P, Golmakani M, Liu F, Moss RA, Vana A, Ignatiadis M, Rugo HS. PMID: 42926110 [PubMed - as supplied by publisher]
	Overall survival from the phase III postMONARCH trial of abemaciclib plus fulvestrant versus placebo plus fulvestrant for HR+, HER2- advanced breast cancer following progression on a prior CDK4/6 inhibitor plus endocrine therapy. Ann Oncol Kalinsky K, Wander SA, Hamilton E, Graff SL, Jeselsohn R, Park KH, Demirci U, Martin M, Layman RM, Hurvitz SA, Sammons S, Kaufman PA, Ravenberg E, Amdur S, Litchfield LM, Bianchini G. PMID: 42926108 [PubMed - as supplied by publisher]
	Efficacy of an AIMP1-Derived Peptide (NeoPep-S) for Radiation-Induced Dermatitis in Breast Cancer Patients: A Prospective Randomized Active-Controlled Trial. Aesthetic Plast Surg Kim MJ, Kim HG, Han HM, Lim HS, Park YJ, Lee IJ. PMID: 42925326 [PubMed - as supplied by publisher]
	Screening Digital Breast Tomosynthesis Performance across Age Groups: Analysis of 302â€‰700 Examinations. Radiol Imaging Cancer Lamb LR, Mercaldo S, Destounis S, Bahl M. PMID: 42925141 [PubMed - indexed for MEDLINE]
	Trastuzumab Rezetecan in ERBB2-Low Advanced Breast Cancer: The HORIZON-Breast06 Randomized Clinical Trial. JAMA Fan Y, Liu Y, Wang Y, Ouyang Q, Zhang Q, Cui J, Li J, Ding Q, Wu X, Wang X, Tong Z, Zeng Y, Wang W, Yan M, Wang Y, Liu X, Li K, Sun Z, Yuan C, Wang T, Xie W, Yao J, Zhou S, Hou J, Ouyang Z, Li Y, Cui S, Zhang X, Zhu X, Xu B. PMID: 42925007 [PubMed - as supplied by publisher]
	The Role of Long Non-Coding RNAs in Breast Cancer Diagnosis and Treatment Based on Evidence from Clinical Studies: A Scoping Review. Epigenomes Zafrakas M, Papasozomenou P, Gavalas I, Emmanouilidis C, Chatzidimitriou M. PMID: 42924724 [PubMed]
	Risk factors for endometrial cancer incidence and regional and ethnic disparities in the USA. J Glob Health Adekanmbi V, Guo F, Wang J, Zhang A, Wang CH, Hoang TN, Sokale I, Uthman O, Berenson AB. PMID: 42924636 [PubMed - indexed for MEDLINE]
	Advances in resistance mechanisms and counterstrategies for antibodyâ€‘drug conjugates in HER2â€‘low and HER2â€‘ultralow breast cancer (Review). Oncol Rep Yu X, Ren M, Yao L. PMID: 42924615 [PubMed - indexed for MEDLINE]
	Elevated Anxiety and Depression Scores are associated with reduced heart rate variability in women with polycystic ovary syndrome. Rev Bras Ginecol Obstet Ribeiro VB, Bernal JVM, Ribeiro IPL, Kogure GS, Philbois SV, Dos Reis RM, Lara LAS, de Souza HCD. PMID: 42924399 [PubMed - indexed for MEDLINE]
	Interconnections between the immune system and infertility in women with polycystic ovary syndrome: a scoping review. Rev Bras Ginecol Obstet Dos Santos LSDS, Rocha GR, Santos GLC, Silva LGO, Calmon MS, de Melo FF. PMID: 42924395 [PubMed - indexed for MEDLINE]
	Performance of HPV testing and liquid-based cytology after negative colposcopy in women with ASC-H, HSIL or AGC cytology. Rev Bras Ginecol Obstet Campos CS, Bovo AC, Fonseca B, Santana IV, Antoniazzi M, Palopoli SM, Possati-Resende JC, Zeferino LC. PMID: 42924372 [PubMed - indexed for MEDLINE]
	Employment after curative breast cancer treatment: the breast cancer and the workforce cohort study. J Natl Cancer Inst Blinder VS, Sampathkumar Y, Patil S, Eberle CE, Suarez J, Narang B, Osorio VL, Filgueira AV, Finik J, Bennett AV, Malik MK, Jung GH, Hwang C, Gany F. PMID: 42924356 [PubMed - as supplied by publisher]
	RE: Endocrine therapy in early-stage estrogen receptor-low breast cancer: a systematic review and meta-analysis. J Natl Cancer Inst Zhu L, Liu L. PMID: 42924349 [PubMed - as supplied by publisher]
	Opportunistic salpingectomy for ovarian cancer prevention Number 12 - 2026. Rev Bras Ginecol Obstet da Silva AL, Cândido EB, Carvalho JP, Derchain SFM, Dos Reis R. PMID: 42923916 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 337002

Page 1 of 16851



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy